Navigation Links
UMass Boston's Venture Development Center Announces New Bio-Science Partner
Date:1/23/2010

Pressure BioSciences Inc. to Join University's R&D Facility

Boston, MA (Vocus) January 21, 2010 -- The University of Massachusetts Boston today announced that South Easton-based Pressure BioSciences Inc., (PBI) a developer of bench-top sample preparation instruments, has moved its research and development operations to the university's Venture Development Center. PBI develops and markets pressure cycling technology that enables safe, rapid, and reproducible extraction of proteins, DNA, RNA, and small molecules from biological samples for biochemical analysis.

This brings the 18,000-square-foot business incubator to 75 percent occupancy since opening in May 2009.

The addition of PBI is expected to greatly benefit the Center for Personalized Cancer Therapy, a joint UMass Boston venture with the Dana-Farber/Harvard Cancer Center to be launched within the VDC. The purpose of the CPCT is to conduct basic and translational research to develop low-cost diagnostic tests focusing on cancers that vary at the molecular level but remain indistinguishable in conventional clinical analyses.

“Our scientists connected with the Center for Personalized Cancer Therapy are excited about collaborating with PBI," said William Brah, executive director of the VDC. “The goals of CPCT are ideally complemented by the cutting-edge, PCT-based sample preparation technology developed by PBI, which can permit tumor biomarkers in ordinary clinical preparations to be more rapidly and effectively analyzed.”

U
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. UMass Boston Opens Venture Development Center to Expand R&D Activity
2. BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool
3. Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution
4. Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities
5. Health Robotics Continues its Global Expansion With December 09 ASHPs Launch of Joint Venture in Canada
6. Bio-Organic Catalyst, Inc. Forms Joint Venture With SIF ICAP Mexico S.A. de C.V. as Exclusive Distribution Hub for Central America, Mexico and Caribbean.
7. Syngenta Ventures Invests in U.S. Biotech Company Metabolon
8. Kansas Bioscience Authority Commits $50 Million to Increase Venture Capital, Accelerate Bioscience Business Growth
9. Southern California Venture Network Announces Recipients of the 2009 Orange County Emerging Growth Awards
10. Southern California Venture Network to Recognize Local Companies At 2009 Emerging Growth Awards
11. RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UMass Boston's Venture Development Center Announces New Bio-Science Partner
(Date:4/1/2015)... - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, ... that Biohaven Pharmaceutical Holding Company Limited (Biohaven), which ... agreement with inVentiv Health for the operational execution ... compound (BHV-0223). Biohaven is engaged ... neuroscience compounds targeting the glutamatergic system. Clinical drug ...
(Date:4/1/2015)... April 1, 2014 /CNW/ - Canada,s ... Board,s (PMPRB) newly released report on Cost Drivers of Public ... that, according to the report, the rates of change in ... a low of -0.8 percent in 2012/13 for a number ... study that examines the costs of medicines without considering their ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 Holomic ... that can read both chromatographic and fluorescent rapid tests ... supplier of high performance, quantitative readers and is already ... The HRDR-400 is a first of its kind offering ... one instrument. , Dr. Neven Karlovac, CEO of ...
(Date:4/1/2015)... 2015 National recruitment firm Slone ... Brad Allen as Head of Sales at Optimal Medicine, ... market. , Allen brings over 20 years experience ... a number of companies including Dell Services Healthcare, Medsphere ... were a perfect fit for accomplishing the goals Optimal ...
Breaking Biology Technology:Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2Slone Partners Fills Head of Sales at Optimal Medicine 2
... Pharmaceuticals is,pleased to announce the introduction of ... on medically based aesthetics and,utilize the clinical ... of,science-based, result-oriented products., Vitivia(TM),s first product ... have long been recognized as important tools ...
... 27 Debiopharm Group,(Debiopharm), a global independent ... and particularly oncology, today,announced the establishment of ... Federale de Lausanne (EPFL), focusing on Signal ... million endowment, the objective,of the chair is ...
... combination vaccine against Ebola and Marburg viruses using ... infection in monkeys. Researchers from the U.S. ... report their results today (Feb. 26) at the ... in Baltimore, MD. , VLPs are one of ...
Cached Biology Technology:JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM) 2Debiopharm and EPFL Establish an Oncology Chair 2Combination vaccine protects monkeys from ebola and Marburg viruses 2
(Date:3/31/2015)... 31, 2015   Guidepoint , a leading global ... Post-Surgical Pain Management TRACKER, part of the Guidepoint ... in the medical device and therapeutics markets. The Post-Surgical ... treatment volumes, market share, and adoption rates across three ... joint surgery. The Post-Surgical Pain Management TRACKER ...
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), a ... announces its biometric payment technology, the Wocket® smart wallet, will ... 30 th . The new 30 ... markets. Gino Pereira , ... ad campaign following the recent initial shipment of Wocket smart ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3
... Researchers at Loyola University Chicago Stritch School of ... the National Institutes of Health to study vitamin D ... evaluate the relation between low vitamin D levels and ... disease. Evidence from numerous previous studies is "inconclusive ...
... N.C. Researchers at the University of North Carolina at ... and paste together different viruses in an effort to create ... clinical trial, the investigators found no side effects from using ... muscle protein in patients with muscular dystrophy. "This trial ...
... Bethesda, MDUsing magnetic resonance imaging (MRI) and nanoparticle technology, ... the growth of laboratory-engineered blood vessels after they have ... step toward ensuring that blood vessels, and possibly other ... taking hold and working as expected. Until now, there ...
Cached Biology News:Loyola receives NIH grant to study vitamin D deficiency in African populations 2Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy 2Yale researchers develop a way to monitor engineered blood vessels as they grow in patients 2
... Beagle serum is collected from fasted Beagle canines ... Available Anticoagulants: N-02: Citrate ... K2EDTA N-08: Potassium Oxalate N-10: ... N-05: ACD N-07: CPD ...
Collected from normal, healthy animals in carefully maintained standing herds of US orgin. Pricing: $45/unit for 1 - 10 units...
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
GOAT ANTI PPP2R5B...
Biology Products: